Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • LipiGO®
  • KABP® Urinary Tract Support
  • KABP® DENTISANI
  • KABP® DENTALAC
  • KABP® Vaginal Health Balance
  • KABP® Digest
  • KABP®-051
  • KABP® Mindbiome
  • Lactobacillus <i>plantarum</i> DR7®
  • KABP® Baby Colic
  • KABP® Cardio
  • <i>Lactobacillus sakei</i> proBio65®
  • KABP® Menopause
  • KABP® Intensive GI
  • KABP® Mature Immune Defense®
Products to Clinical Evidence (mobile)
  • Effects of potential probiotic strains on the fecal microbiota and metabolites of d-galactose-induced aging rats fed with high-fat diet

    2020

    Lew LC, et al.

    Read
  • Lactobacillus plantarum DR7 modulated bowel movement and gut microbiota associated with dopamine and serotonin pathways in stressed adults

    2020

    Liu G, et al

    Read
  • Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: A randomised, double-blind, placebo-controlled study

    2019

    Chong HX, et al

    Read